ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,853 | -35.6% | 48,286 | -19.3% | 0.00% | – |
| Q2 2023 | $444,206 | -52.9% | 59,866 | -40.1% | 0.00% | – |
| Q1 2023 | $943,914 | +119.0% | 99,885 | +146.8% | 0.00% | – |
| Q4 2022 | $431,037 | +16.5% | 40,473 | -19.3% | 0.00% | – |
| Q3 2022 | $370,000 | +58.1% | 50,172 | +3.1% | 0.00% | – |
| Q2 2022 | $234,000 | +125.0% | 48,655 | +138.4% | 0.00% | – |
| Q1 2022 | $104,000 | -43.5% | 20,408 | -33.2% | 0.00% | – |
| Q4 2021 | $184,000 | -52.8% | 30,569 | -30.5% | 0.00% | – |
| Q3 2021 | $390,000 | +129.4% | 43,972 | +104.6% | 0.00% | – |
| Q2 2021 | $170,000 | +385.7% | 21,489 | +368.3% | 0.00% | – |
| Q1 2021 | $35,000 | +34.6% | 4,589 | +39.5% | 0.00% | – |
| Q4 2020 | $26,000 | -92.0% | 3,289 | -90.3% | 0.00% | – |
| Q3 2020 | $327,000 | – | 33,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 37,500 | $225,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 73,366 | $441,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 56,673 | $341,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $60,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $535,000 | 0.01% |
| EMFO, LLC | 1,666 | $10,000 | 0.01% |
| Virtu Financial LLC | 14,020 | $84,000 | 0.01% |
| Retirement Group, LLC | 1,129 | $17,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 86,866 | $522,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $4,000 | 0.00% |